Analysis of long-term outcomes of 3200 liver transplantations over two decades - A single-center experience

被引:314
作者
Busuttil, RW
Farmer, DG
Yersiz, H
Hiatt, JR
McDiarmid, SV
Goldstein, LI
Saab, S
Han, S
Durazo, F
Weaver, M
Cao, C
Chen, T
Lipshutz, GS
Holt, C
Gordon, S
Gornbein, J
Amersi, F
Ghobrial, RM
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dumont UCLA Liver Transplant Ctr, Dept Surg, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Dumont UCLA, Los Angeles, CA 90095 USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biomath, Dumont UCLA, Los Angeles, CA 90095 USA
[4] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Dumont UCLA, Los Angeles, CA 90095 USA
[5] Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Dumont UCLA, Los Angeles, CA 90095 USA
关键词
D O I
10.1097/01.sla.0000164077.77912.98
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: Few studies have evaluated long-term outcomes after orthotopic liver transplantation (OLT). This work analyzes the experience of nearly 2 decades by the same team in a single center. Outcomes of OLT and factors affecting survival were analyzed. Methods: Retrospective analysis of 3200 consecutive OLTs that were performed at our institution, between February 1984 and December 31, 2001. Results: Of 2662 recipients, 578 (21.7%) and 659 (24.7%) were pediatric and urgent patients, respectively. Overall 1-, 5-, 10-, and 15-year patient and graft survival estimates were 81%, 72%, 68%, 64% and 73%, 64%, 59%, 55%, respectively. Patient survival significantly improved in the second (1992-2001) versus the era 1 (1984-1991) of transplantation (P < 0.001). Similarly, graft survival was better in the era II of transplantation (P < 0.02). However, biliary and infectious complications increased in era II. When OLT indications were considered, best recipient survival was obtained in children with biliary atresia (82%, 79%, and 78% at 1, 5, and 10 years, respectively), while malignant disease in adult patients resulted in the worst outcomes of 68% and 43% at 1 and 5 years, post-OLT. Further, patients < 18 years and nonurgent recipients exhibited superior survival when compared with recipients > 18 years (P < 0.001) or urgent patients (P < 0.001). Of 13 donor and recipient variables, era of OLT, recipient age, urgent status, donor age, donor length of hospital stay, etiology of liver disease, retrans- plantation, warm and cold ischemia, but not graft type (whole, split, living-donor), significantly impacted patient survival. Conclusions: Long-term benefits of OLT are greatest in pediatric and nonurgent patients. Multiple factors involving the recipient, etiology of liver disease, donor characteristics, operative variables, and surgical experience influence long-term survival outcomes. By balancing and matching these factors with a given recipient, optimum results can be achieved.
引用
收藏
页码:905 / 916
页数:12
相关论文
共 50 条
  • [11] COOPER JD, 1987, J THORAC CARDIOV SUR, V93, P173
  • [12] EARLY DEATH OR RETRANSPLANTATION IN ADULTS AFTER ORTHOTOPIC LIVER-TRANSPLANTATION - CAN OUTCOME BE PREDICTED
    DOYLE, HR
    MARINO, IR
    JABBOUR, N
    ZETTI, G
    MCMICHAEL, J
    MITCHELL, S
    FUNG, J
    STARZL, TE
    [J]. TRANSPLANTATION, 1994, 57 (07) : 1028 - 1036
  • [13] Hepatic retransplantation - An analysis of risk factors associated with outcome
    Doyle, HR
    Morelli, F
    McMichael, J
    Doria, C
    Aldrighetti, L
    Starzl, TE
    Marino, IR
    [J]. TRANSPLANTATION, 1996, 61 (10) : 1499 - 1505
  • [14] Early graft function after pediatric liver transplantation - Comparison between in situ split liver grafts and living-related liver grafts
    Farmer, DG
    Yersiz, H
    Ghobrial, RM
    McDiarmid, SV
    Gornbein, J
    Le, H
    Schlifke, A
    Amersi, F
    Maxfield, A
    Amos, N
    Restrepo, GC
    Chen, P
    Dawson, S
    Busuttil, RW
    [J]. TRANSPLANTATION, 2001, 72 (11) : 1795 - 1802
  • [15] FONKALSRUD EW, 1968, SURG GYNECOL OBSTETR, V127, P1051
  • [16] Retransplantation for recurrent hepatitis C in the model for end-stage liver disease era: How should we or shouldn't we?
    Ghobrial, RM
    [J]. LIVER TRANSPLANTATION, 2003, 9 (10) : 1025 - 1027
  • [17] Pretransplant model to predict posttransplant survival in liver transplant patients
    Ghobrial, RM
    Gornbein, J
    Steadman, R
    Danino, N
    Markmann, JF
    Holt, C
    Anselmo, D
    Amersi, F
    Chen, P
    Farmer, DG
    Han, S
    Derazo, F
    Saab, S
    Goldstein, LI
    McDiarmid, SV
    Busuttil, RW
    [J]. ANNALS OF SURGERY, 2002, 236 (03) : 315 - 323
  • [18] Retransplantation for recurrent hepatitis C
    Ghobrial, RM
    [J]. LIVER TRANSPLANTATION, 2002, 8 (10) : S38 - S43
  • [19] Donor and recipient outcomes in right lobe adult living donor liver transplantation
    Ghobrial, RM
    Saab, S
    Lassman, C
    Lu, DSK
    Raman, S
    Limanond, P
    Kunder, G
    Marks, K
    Amersi, T
    Anselmo, D
    Chen, P
    Farmer, D
    Han, S
    Durazo, F
    Goldstein, LI
    Busuttil, RW
    [J]. LIVER TRANSPLANTATION, 2002, 8 (10) : 901 - 909
  • [20] A 10-year experience of liver transplantation for hepatitis C: Analysis of factors determining outcome in over 500 patients
    Ghobrial, RM
    Steadman, R
    Gornbein, J
    Lassman, C
    Holt, CD
    Chen, P
    Farmer, DG
    Yersiz, H
    Danino, N
    Collisson, E
    Baquarizo, A
    Han, SS
    Saab, S
    Goldstein, LI
    Donovan, JA
    Esrason, K
    Busuttil, RW
    [J]. ANNALS OF SURGERY, 2001, 234 (03) : 384 - 393